1. What Is the Continuous Glucose Monitoring Market?
The Continuous Glucose Monitoring Market covers wearable electrochemical sensors measuring interstitial glucose every one to five minutes providing real-time glucose trends, hypoglycemia alerts, and comprehensive glycemic pattern data for diabetes management. Endocrinologists, diabetes educators, and people with type 1 and insulin-treated type 2 diabetes deploy CGM systems for continuous glucose awareness, closed-loop insulin delivery integration, and clinical glycemic management. The market includes professional CGM for short-term diagnostic use, personal CGM for ongoing management, and integrated CGM within artificial pancreas systems.
2. Continuous Glucose Monitoring Market Size & Forecast
3. Emerging Technologies
- Implantable glucose sensors providing 90 to 180 day continuous glucose monitoring from a single subcutaneous device eliminating frequent wearable sensor changes.
- CGM-integrated metabolic health platforms combining glucose monitoring with activity, sleep, and nutrition data for holistic metabolic management.
- AI-powered hypoglycemia prediction algorithms detecting imminent glucose drops from CGM trend data to enable preventive carbohydrate intake.
- Non-invasive optical CGM technology measuring interstitial glucose through skin without electrochemical sensor insertion.
Similar technologies are also transforming adjacent markets. Learn more in our Point Of Care Testing Market.
4. Key Market Opportunity
Consumer CGM for non-insulin type 2 diabetes represents the largest addressable market expansion. Closed-loop artificial pancreas CGM integration drives premium system adoption and sustained consumable revenue. Implantable long-duration CGM adoption represents the most significant convenience improvement pipeline opportunity. Emerging market CGM access expansion is the largest long-term geographic opportunity.
5. Top Companies in the Continuous Glucose Monitoring Market
The following organisations hold leading positions in the Continuous Glucose Monitoring Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Dexcom
- Abbott Laboratories
- Medtronic
- Senseonics
- Roche Diagnostics
- Tandem Diabetes Care
- Insulet
- GlucoMe
- Biolinq
- Movano Health
6. Market Segmentation
The Continuous Glucose Monitoring Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Product | Real-Time CGM Receiver and SensorIntermittently Scanned CGMProfessional CGMIntegrated Artificial Pancreas CGMImplantable Long-Duration CGM |
| By Diabetes Type | Type 1 Diabetes CGMInsulin-Treated Type 2 CGMNon-Insulin Type 2 Diabetes CGMGestational Diabetes CGM |
| By Wear Duration | 10-Day Sensor14-Day Sensor15-Day SensorExtended Wear Implantable Sensor |
| By End-User | Home Self-ManagementHospital and ClinicalRemote Patient Monitoring |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Continuous Glucose Monitoring Market trajectory over the forecast period:
Non-insulin type 2 diabetes CGM expansion is the largest commercial growth driver as Dexcom Stelo and Abbott Lingo consumer CGM products target the vast non-insulin type 2 and prediabetes population beyond the traditional CGM market.FDA clearance for OTC consumer CGM without prescription requirement creates a mass-market glucose monitoring opportunity substantially larger than the established prescription CGM market. The consumer CGM expansion is transforming CGM from specialty prescription device to mass-market wellness product.
Artificial pancreas closed-loop integration is the most clinically significant CGM application as CGM-integrated automated insulin delivery eliminates manual insulin dosing decisions for type 1 diabetes.Tandem Control-IQ, Medtronic MiniMed 780G, and Omnipod 5 closed-loop systems are demonstrating superior time-in-range versus manual insulin management. The closed-loop adoption is driving premium CGM system demand and sustained sensor consumable revenue from algorithmic insulin delivery users.
Extended sensor wear duration is improving CGM convenience as 14-day and 15-day wear sensors reduce sensor change frequency burden.Abbott FreeStyle Libre 3 extending wear to 15 days and Dexcom G7 at 10 days are improving patient adherence. The wear duration extension reduces consumable unit consumption per patient per year while improving adoption rates among patients deterred by frequent sensor changes.
For related market intelligence, see the Blood Glucose Monitoring Market.
8. Segmental Analysis
By product, the real-time CGM receiver and sensor segment dominated the Continuous Glucose Monitoring Market in 2025, as real-time CGM providing continuous glucose readings with trend arrows and alerts represents the most clinically comprehensive CGM format sustaining the largest adoption among type 1 diabetes patients and high-intensity type 2 diabetes management globally.
By diabetes type, the non-insulin type 2 diabetes CGM segment is projected to register the highest growth rate through 2034, as OTC consumer CGM market expansion targeting the vast non-insulin type 2 and wellness population creates the largest new addressable CGM market growth opportunity.
9. Regional Analysis
Regional demand patterns across the Continuous Glucose Monitoring Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Continuous Glucose Monitoring Market in 2025, accounting for around 54 percent of global revenue. The United States type 1 diabetes CGM adoption rate is the world's highest driven by comprehensive insurance coverage and physician recommendation. Dexcom and Abbott FreeStyle Libre generate dominant U.S. CGM revenue. Moreover, U.S. FDA clearance of OTC consumer CGM products is opening a substantially larger addressable market beyond prescription-only diabetes management.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR in the Continuous Glucose Monitoring Market through 2034. The region's large type 2 diabetes population combined with rapidly growing CGM awareness and access is driving substantial market growth. Chinese CGM market expansion through domestic development and international brand adoption is creating substantial regional demand. Japanese and Korean diabetes technology adoption is growing systematically as CGM reimbursement expands.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Continuous Glucose Monitoring Market was valued at USD 6.25 Bn in 2025 and is projected to reach USD 28.57 Bn by 2034, growing at a CAGR of 18.4% over the 2026–2034 forecast period.
The Continuous Glucose Monitoring Market is projected to grow at a CAGR of 18.4% from 2026 to 2034.
North America dominated the Continuous Glucose Monitoring Market in 2025, accounting for around 54 percent of global revenue.
The leading companies in the Continuous Glucose Monitoring Market include Dexcom, Abbott Laboratories, Medtronic, Senseonics, Roche Diagnostics, Tandem Diabetes Care, Insulet, GlucoMe, Biolinq, Movano Health.
Non-insulin type 2 diabetes cgm expansion is the largest commercial growth driver as dexcom stelo and abbott lingo consumer cgm products target the vast non-insulin type 2 and prediabetes population beyond the traditional cgm market.
By product, the real-time CGM receiver and sensor segment dominated the Continuous Glucose Monitoring Market in 2025, as real-time CGM providing continuous glucose readings with trend arrows and alerts represents the most clinically comprehensive CGM format sustaining the largest adoption among type 1 diabetes patients and high-intensity type 2 diabetes management globally.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.